Otsuka Canada Pharmaceuticals Inc
Registration:
2
of
2
(2025-04-15
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Discuss Product Listing Agreements of Otsuka Canada Pharmaceutical Inc innovative medicine products with BC Pharmacare
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Mental Health and Addictions
|
Recommendations regarding job creation and growth of BC's knowledge-based economy. Business incentives for and/or barriers to investment in BC. Sharing of information on Otsuka's global research investment platform and opportunities for increase investment in BC.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Science and Technology
|
Seeking reimbursement for Otsuka Canada Pharmaceutical Inc nephrology medicines through the BC Renal Agency program under the Provincial Health Services Authority
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|
Through Innovative Medicines of Canada (IMC) to further promote the contributions and positive impact of the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|